OXURION (EBR:OXUR) | Finanzwire

PRESS RELEASE

published on 09/08/2025 at 18:00, 6 months 19 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding change in shareholding. Oxurion specializes in acquiring majority stakes in European pharmaceutical subcontractors

Transparency Notification Shareholding Change Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
BRIEF

published on 09/01/2025 at 18:05, 6 months 26 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Atlas Special Opportunities Oxurion Participation Thresholds
PRESS RELEASE

published on 09/01/2025 at 18:00, 6 months 26 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications under Belgian legislation from Atlas Special Opportunities II, LLC regarding changes in voting securities holdings

Oxurion NV Belgian Legislation Transparency Notifications Voting Securities Atlas Special Opportunities II LLC
BRIEF

published on 08/07/2025 at 18:05, 7 months 20 days ago

Oxurion receives transparency notifications from UBS Group AG

Investors Actions Transparency UBS Group AG Oxurion
PRESS RELEASE

published on 08/07/2025 at 18:00, 7 months 20 days ago

Oxurion Receives Transparency Notifications from UBS Group AG
Oxurion NV received transparency notifications from UBS Group AG regarding share holdings, in compliance with Belgian Transparency legislation. The company is a biopharmaceutical group focusing on therapeutic innovation and clinical research technologies

Clinical Research Biopharmaceutical UBS Group AG Oxurion NV Transparency Notifications
BRIEF

published on 08/06/2025 at 18:05, 7 months 21 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 08/06/2025 at 18:00, 7 months 21 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC as per Belgian Transparency legislation. Company combines therapeutic innovation with technology for new treatments

Clinical Research Shareholding Changes Oxurion NV Therapeutic Innovation Transparency Notifications
BRIEF

published on 08/04/2025 at 18:05, 7 months 23 days ago

Oxurion Secures EUR 30M for Diversification into Digital Assets

Funding Investment Cryptocurrencies Biopharmaceuticals Oxurion
PRESS RELEASE

published on 08/04/2025 at 18:00, 7 months 23 days ago

Oxurion announces it obtained an improved indicative EUR 30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets
Oxurion NV receives €30 million financing offer from Atlas Special Opportunities for investment in digital assets. Company remains confident in closing the transaction by August 2025

Investment Digital Assets Oxurion NV Financing Offer August 2025
BRIEF

published on 08/04/2025 at 08:35, 7 months 23 days ago

Oxurion completes acquisition of 72% of Axiodis CRO

Acquisition External Growth Clinical Data Oxurion Axiodis CRO

Published on 03/27/2026 at 15:35, 3 hours 55 minutes ago

SouthGobi Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Published on 03/27/2026 at 12:30, 7 hours ago

Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 7 hours 30 minutes ago

Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 12:00, 7 hours 30 minutes ago

Athena Gold Announces Share Consolidation
Published on 03/27/2026 at 11:00, 8 hours 30 minutes ago

RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation

View all ACCESSWIRE

Published on 03/27/2026 at 18:25, 1 hour 4 minutes ago

Thieves Make a Break For It as 12 Tonnes of KITKAT Go Missing
Published on 03/27/2026 at 18:20, 1 hour 9 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/27/2026 at 18:18, 1 hour 11 minutes ago

CPI Europe publishes financial results for 2025
Published on 03/27/2026 at 17:45, 1 hour 44 minutes ago

DKSH’s 93rd Annual General Meeting 2026
Published on 03/27/2026 at 17:45, 1 hour 44 minutes ago

ENOGIA: 2025 annual results

View all EQS

Published on 03/27/2026 at 19:06, 23 minutes ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 37 minutes ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 49 minutes ago

2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 1 hour 36 minutes ago

Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 1 hour 45 minutes ago

PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025

View all LES ECHOS COMFI WIRE

News